Footwear company Caleres (NYSE:CAL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.6% year on year to $695.5 million. Its non-GAAP profit of $0.47 per share was 27% above analysts’ consensus estimates.

Is now the time to buy CAL? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Caleres delivered revenue growth in Q2 that fell short of Wall Street’s expectations, but profitability was meaningfully above consensus as margins improved. Management highlighted broad-based gains across its brand portfolio, with notable strength in women's fashion footwear and international markets. CEO John W. Schmidt emphasized that both lead brands and the broader brand lineup experienced sales and earnings growth, particularly pointing to strong demand for ballet flats, pumps, and loafers. Meanwhile, persistent softness in the Famous Footwear segment was attributed to a delayed back-to-school season and a consumer shift away from lifestyle athletic shoes, driving the need for promotional activity and inventory adjustments.

Looking ahead, Caleres’ improved profit outlook is driven by continued momentum in its brand portfolio and ongoing actions to reposition the Famous Footwear business. Management expects the international segment to remain a key growth area, while the company is actively shifting product assortments to capitalize on rising demand for fashion footwear. CFO Daniel Karpel noted that guidance assumes ongoing promotional pressure in lifestyle athletic and the return of tariffs, but he emphasized flexibility in sourcing and a commitment to operational discipline. CEO Schmidt stated, “We believe Caleres is uniquely positioned to capitalize on these trends in both segments of our business.”

Key Insights from Management’s Remarks

Management attributed the quarter’s margin expansion and earnings growth to strong brand portfolio performance, international sales momentum, and a deliberate pivot in product mix at Famous Footwear.

• Brand portfolio momentum: The company’s brand portfolio, including Sam Edelman, Allen Edmonds, and Naturalizer, saw broad-based growth with Sam Edelman achieving double-digit sales increases and gaining market share in women’s fashion footwear. Management cited high demand for flats, pumps, and loafers, as well as positive consumer response to new collections and international store openings.
• International sales acceleration: International business, especially in China and other key regions, was a standout, with sales rising over 50% and high-teens organic growth. Leadership pointed to significant runway for global expansion, as international still represents less than 10% of total sales, indicating future growth potential.
• Famous Footwear headwinds: The Famous Footwear segment faced continued challenges from a delayed back-to-school season and a consumer shift away from lifestyle athletic shoes toward fashion styles. Management responded by reducing receipts, increasing clearance activity, and rebalancing the product mix to favor fashion and premium brands.
• Product assortment pivots: Actions were taken to decrease exposure to underperforming lifestyle athletic inventory while increasing investment in performance athletic and fashion categories. The company highlighted upcoming floor takeovers for non-athletic brands and stronger trends in kids’ fashion and dress shoes.
• Margin management: Margin improvement in the brand portfolio was supported by favorable channel and product mix, lower markdowns, and ongoing tariff mitigation efforts. However, Famous Footwear margins were pressured by the need for promotional activity to clear excess athletic inventory, with management expecting further promotional intensity in the near term.

Drivers of Future Performance

Caleres’ outlook is shaped by continued strength in its brand portfolio, international expansion, and the need to address ongoing challenges at Famous Footwear.

• Brand portfolio expansion: Management expects the brand portfolio to drive future growth, underpinned by strong consumer demand for fashion-forward products, international store rollouts, and further development of new product franchises. Initiatives such as the men’s line launch at Sam Edelman and expansion in China are set to support higher sales and profitability.
• Famous Footwear repositioning: The company is actively rebalancing Famous Footwear’s assortment, shifting away from lifestyle athletic shoes and increasing focus on premium and fashion segments. Management anticipates that these changes, coupled with inventory discipline, will stabilize sales and improve gross margin over time, though near-term promotional pressure will persist.
• Tariff and sourcing flexibility: Caleres’ guidance incorporates expectations for new tariffs in the coming quarters. The company plans to remain flexible in its sourcing strategy to mitigate potential cost impacts, while maintaining operational discipline and closely monitoring the pricing environment for both fashion and athletic categories.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will be watching (1) the effectiveness of Famous Footwear’s product mix shift and inventory management, (2) sustained international growth, especially in China and other underpenetrated markets, and (3) ongoing margin improvement in the brand portfolio despite external risks like tariffs. Execution in these areas will be critical to Caleres’ ability to deliver on its profit recovery strategy.

Caleres currently trades at $12.95, up from $12.03 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.